Enjoy your project.
Synapse is a firm specialized in the high quality management of complex research and development projects in the biomedical sector.
Synapse partners with national and international organisations, both public and private. Our company goes beyond classical project management and brings in added value capabilities in team management, vision management, strategic thinking and project intelligence. Synapse’s expertise extends to market knowledge, business planning and valorization of research results.
OUR PROJECTS
-
PARADIGM
Current Projects
Patients Active in Research and Dialogues for an Improved Generation of Medicines The overall goal is to provide a framework that allows structured, meaningful, sustainable and... -
eTRANSAFE
Current Projects
Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFE project aims to develop an advanced data integration infrastructure together with innovative computational methods to improve the... -
Drive
Current Projects
Development of Robust and Innovative Vaccine Effectiveness DRIVE aims at developing a governance model between public and private entities to enable a sustainable network of influenza... -
RESCEU
Current Projects
RESCEU aims to investigate serious lung infections caused by respiratory syncytial virus (RSV) that particularly affect babies and older people, and those with weakened immune systems,... -
TransQST
Current Projects
TransQST aims to develop novel computational approaches using the best available data from the public and private domains to improve the understanding of adverse drug reactions... -
HARMONY
Current Projects
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONY aims at capturing, integrating, analysing and harmonising anonymous patient data from high-quality multidisciplinary sources to... -
ROADMAP
Current Projects
Real world Outcomes across the AD spectrum for better care: Multi-modal data Access Platform ROADMAP aims to create the conditions for an open collaboration that yields... -
AMYPAD
Current Projects
Amyloid imaging to prevent Alzheimer’s Disease The Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) project aims at studying the onset, dynamics, and clinical relevance of brain... -
EPAD
Current Projects
European Prevention of Alzheimer’s Dementia The European Prevention of Alzheimer’s Dementia (EPAD) project aims to develop an infrastructure that efficiently enables the undertaking of adaptive, multi-arm... -
ADVANCE
Current Projects
Accelerated development of vaccine benefit-risk collaboration in Europe The goal of the ADVANCE project is to develop a blueprint for a framework capable of rapidly delivering... -
EMIF
Current Projects
European Medical Information Framework The EMIF project aims to be the trusted European hub for health care data intelligence, enabling new insights into diseases and treatments....
OUR PARTNERS
Check the full list of partners
LATEST NEWS
-
Join the DRIVE network!
No Comments
The DRIVE Project aims at developing a governance model between public and private entities to enable a sustainable network of influenza vaccine effectiveness (IVE). Influenza is... -
AMYPAD diagnostic and patient management study (DMPS) enrolled its first research participant in Geneva last Friday
No Comments
The Amyloid imaging to prevent Alzheimer’s Disease project (AMYPAD) aims at studying the onset, dynamics, and clinical relevance of brain β-amyloid in the spectrum from normal... -
The first TransQST General Assembly meeting held in Finland
No Comments
The TransQST project, launched in January 2017, aims to develop novel computational approaches using the best available data from the public and private domains to improve... -
Synapse gathers the ROADMAP consortium partners for the 5th General Assembly Meeting
No Comments
ROADMAP aspires to create the conditions for an open collaboration that yields consensual and efficient uses of RWE for the benefit of Alzheimer’s Disease patients and... -
Synapse organises the 6th iPiE Forum Meeting at the Biomedical Research Park of Barcelona
No Comments
iPiE (Intelligence-led Assessment of Pharmaceuticals in the Environment) aims to develop predictive tools that use information from toxicological studies, in silico models and existing datasets on... -
EMIF organises a public symposium “Liberating Evidence from European Health Data” within its closing meeting in Brussels
No Comments
During the 16th – 18th of April, the closing EMIF meeting was held in Brussels. The main issues addressed during the meeting were project’s objectives and... -
PARADIGM, a new IMI project managed by SYNAPSE centered in Patient Engagement, kicks off in Brussels, with the 1st Open Patient Engagement Forum
No Comments
The PARADIGM (Patients Active in Research and Dialogues for an Improved Generation of Medicines) project, funded by IMI-JU 2, was officially launched in Brussel on April... -
SYNAPSE attended the first Observational Health Data Sciences and Informatics (OHDSI) Symposium in Rotterdam
No Comments
The first European OHDSI Symposium called “Bridging Europe” was held in Rotterdam on the 23rd and 24th of March. The Observational Health Data Sciences and Informatics (OHDSI)... -
eTRANSAFE was presented at the PhUSE Computational Sciences Symposium in March 2018
No Comments
The Computational Sciences Symposium (CSS) celebrated its 7th annual event in Silver Spring, Maryland (US). The event brings together Academia, Regulators, Industry, and technology providers to... -
Brain Awareness Week, 12th – 18th March
No Comments
The Brain Awareness Campaign is officially celebrated during this week, and we would like to use it as an opportunity to bring attention to brain... -
Carlos Díaz presented the ROADMAP project at the XI Annual Conference of Biomedical Research Technology Platforms in Barcelona
No Comments
On the 5th and 6th of March, Barcelona hosted XI Annual Conference of Biomedical Research Technology Platforms. Different advances in Innovative Medicines, Nanomedicine, Health Technology and...
• Master in Communication, PR and Protocol, ESERP Business School
• Degree in Linguistics, Universitat de Barcelona
• Degree in Tourism, Universitat de Barcelona – Centre d’Estudis Tècnics Turístics
• MSc in Neuroscience, Universitat de Barcelona, Universitat Pompeu Fabra
• PhD in Physical Chemistry, Universidad Autónoma de Madrid
• Ph.D. In Biomedical Research, Universitat Pompeu Fabra
• Master’s degree in History, University of Turin (IT)
• Master in European Studies and Project Management, Université Catholique de Louvain and Belgian Italian Chamber of Commerce
• Degree in Social Sciences, Universidad de Vigo
• Ph.D. in Molecular Toxicology, University of Colorado Boulder
• B.A. in Economics with Honors and Distinction from Stanford University
• Ph.D. In Computational and Theoretical Chemistry, Universitat de Girona
• Associate Degree of System Analyst and Infrastructure
